A Phase 2 trial testing experimental therapy CAL101 in people with IPF is recruiting participants. CAL101 has been granted ...
Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...
Hosted on MSN
Novel PET imaging approach detects heart damage in patients with non-ischemic cardiomyopathy
A new PET/CT imaging technique that visualizes activated fibroblasts in the heart muscle enables early detection of multiple forms of cardiomyopathy, according to research presented at the Society of ...
Blood tests, ultrasounds, and MRIs often fail to detect the earliest changes in cardiomyopathy, when fibroblasts activate and start the scarring process. Since early detection is crucial for the best ...
Researchers in Dr. Louis Weiner’s lab at the Georgetown University Lombardi Comprehensive Cancer Center are examining ...
Avacta Therapeutics (AIM: AVCT, ‘Avacta’, ‘the Company’), a clinical stage biopharmaceutical company developing pre|CISION ®, a tumor-activated oncology delivery platform, today ...
Zhongshan Innovation New Drug Development Co. Ltd. has described conjugates comprising a chelating ligand moiety, a fibroblast activation protein α (FAP) ligand and integrin αvβ3 or integrin αvβ6 ...
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and maximize tumor controlLONDON and PHILADELPHIA, ...
The humble henna plant, famed for its vibrant dye, could hold the key to healing scarred livers. In a new study, researchers have found that its active compound, lawsone, may stop and even reverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results